Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Pitavastatin (Standard)

Pitavastatin (Standard) is the analytical standard of Pitavastatin. This product is intended for research and analytical applications. Pitavastatin (NK-104) is a potent hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. Pitavastatin inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in HepG2 cells. Pitavastatin is an efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer. Pitavastatin also possesses anti-atherosclerotic, anti-asthmatic, anti-osteoarthritis, antineoplastic, neuroprotective, hepatoprotective and reno-protective effects[1][2][3][8].

Product Specifications

CAS Number

147511-69-1

UNSPSC

12352100

Target

Apoptosis; Autophagy; HMG-CoA Reductase (HMGCR) ; Mitophagy; Reference Standards

Related Pathways

Apoptosis; Autophagy; Metabolic Enzyme/Protease; Others

Field of Research

Cancer; Metabolic Disease; Neurological Disease; Cardiovascular Disease

Smiles

O=C(O)C[C@H](O)C[C@H](O)/C=C/C1=C(C2=CC=C(F)C=C2)C3=CC=CC=C3N=C1C4CC4

Molecular Formula

C25H24FNO4

Molecular Weight

421.46

References & Citations

[1]Morikawa S, et al. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells. J Atheroscler Thromb. 2000;7 (3) :138-44.|[2]Katsuki S, et al. Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes. Circulation. 2014 Feb 25;129 (8) :896-906.|[3]Tajiri K, et al. Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice. Cardiovasc Drugs Ther. 2013 Oct;27 (5) :413-24.|[4]Hamano T, et al. Pitavastatin decreases tau levels via the inactivation of Rho/ROCK. Neurobiol Aging. 2012 Oct;33 (10) :2306-20.|[5]de Wolf E, et al.Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer.Sci Rep. 2017 Jul 14;7 (1) :5410.|[6]Demir B, et al. The Effects of Pitavastatin on Nuclear Factor-Kappa B and ICAM-1 in Human Saphenous Vein Graft Endothelial Culture. Cardiovasc Ther. 2019 May 2;2019:2549432.|[7]Hayashi T, et al. A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits. Atherosclerosis. 2004 Oct;176 (2) :255-63.|[8]Sahebkar A, et al. A comprehensive review on the lipid and pleiotropic effects of pitavastatin. Prog Lipid Res. 2021 Nov;84:101127.

Shipping Conditions

Room temperature

Scientific Category

Reference Standards

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Aurora A (AURKA) (NM_198433) Human Over-expression Lysate
LY403678 100 µg

Aurora A (AURKA) (NM_198433) Human Over-expression Lysate

Sign In for Pricing
View Details
AZ 5104 Hydrochloride
TRC-A795180-1MG 1 mg

AZ 5104 Hydrochloride

Sign In for Pricing
View Details
Medium Binding 96 well Solid plates - Clear PS
MC0F-MB 50x 96 Well Plates

Medium Binding 96 well Solid plates - Clear PS

Sign In for Pricing
View Details
DHPMA
TRC-D965260-50MG 50 mg

DHPMA

Sign In for Pricing
View Details
Valspodar
TRC-V096100-1MG 1 mg

Valspodar

Sign In for Pricing
View Details
Mouse TXB2 (Thromboxane B2) ELISA Kit
E-EL-M1144-01 24 Tests

Mouse TXB2 (Thromboxane B2) ELISA Kit

Sign In for Pricing
View Details